Floatz logo

NEPENTHE

Insulin Sensitivity

Universidad Santo TomasSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

2 Active assets in the Insulin Sensitivity cohort.

Asset / SponsorPhaseRating
Letrozole
University of Virginia
Phase 4BB
ORSYTHIA COMPONENT ETHINYL ESTRADIOL
Federico II University
Phase 3B
Levonorgestrel
Federico II University
Phase 3B
Bifidobacterium
Bogomolets National Medical University
N/AD
SODIUM PHOSPHATE
University of Alabama at Birmingham
N/AD

View all 13 →

Same molecule, other indications

NEPENTHE is also rated in:

PainDormant
BBB
Indicative ·
77 / 100
View asset →
cancer of unknown primary siteDormant
BBB
Indicative ·
75 / 100
View asset →
chronic pain syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →